A univariate analysis revealed that low level of BAG2 [hazard ratio (HR): 0.508; 95% confidence interval (CI): 0.357–0.722; p < 0.001], good cancer status (HR: 0.372, CI: 0.234–0.590; p < 0.001), early T stage (HR: 0.479, CI: 0.334–0.685; p < 0.001), without lymph node metastasis (HR: 0.676, CI: 0.469–0.973; p = 0.035), and without distant metastasis (HR: 0.613, CI: 0.426–0.883; p = 0.009) were all associated with longer OS (Table 1a). This evidence concerns the gene BAG2 and cancer.